Guardant Health (GH) Depreciation & Amortization (CF) (2017 - 2026)

Guardant Health has disclosed Depreciation & Amortization (CF) across 10 years of filings, most recently posting $9.6 million for Q2 2026.

• In Q2 2026, Depreciation & Amortization (CF) fell 4.79% year-over-year to $9.6 million; the TTM figure through Jun 2026 stood at $38.5 million (down 6.94% YoY), while the FY2025 annual figure was $39.7 million, down 6.25% from the prior year.
• Depreciation & Amortization (CF) came in at $9.6 million for Q2 2026 at Guardant Health, up from $9.4 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $11.0 million in Q3 2023 to a low of $7.2 million in Q1 2022.
• Average Depreciation & Amortization (CF) over 5 years is $10.0 million, with a median of $10.2 million recorded in 2022.
• Year-over-year, Depreciation & Amortization (CF) surged 76.89% in 2022 and fell 11.23% in 2025.
• Over 5 years, Depreciation & Amortization (CF) stood at $10.2 million in 2022, then advanced by 6.87% to $10.9 million in 2023, then decreased by 3.81% to $10.5 million in 2024, then retreated by 3.86% to $10.0 million in 2025, then fell by 4.87% to $9.6 million in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $9.6 million in Q2 2026, $9.4 million in Q1 2026, and $10.0 million in Q4 2025.